-
Enviro Infra
284.00 392.00(%) -
Mamata Machinery
525.00 649.00(%) -
Glenmark Pharma.
2,286.15 2,286.15(%) -
Crizac
364.00 364.00(%) -
TCS
3,261.35 3,060.25(%) -
Eternal Ltd
264.90 304.50(%) -
Hind. Unilever
2,530.00 3,034.50(%) -
JP Power Ven.
24.86 24.86(%) -
Indian Renewable
159.05 137.00(%) -
Tata Elxsi
5,679.00 4,601.05(%) -
Infosys
1,563.25 1,307.10(%) -
Netweb Technol.
1,989.00 3,060.00(%) -
Reliance Industr
1,490.10 1,115.55(%) -
RattanIndia Pow.
15.90 8.44(%) -
Meta Infotech
236.25 236.25(%) -
Interglobe Aviat
5,937.00 6,019.20(%) -
Quality Power El
760.90 270.60(%) -
Bharat Electron
404.95 240.15(%) -
ICICI Bank
1,414.55 1,153.30(%) -
Kirloskar Oil
895.60 544.15(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Cipla Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 114.0
- ISIN : INE059A01026
-
Today’s Low
1,470.00 -
Today’s High
1,490.50

-
Open
1,480.00 -
Perv Close
1,477.80 -
52W Low
1,335.00 -
52W High
1,702.05
Key Indicators
-
P/E(TTM)
24.92
-
Mar.Cap (₹Cr.)
119,944.61
-
Div & Yield %
1.08
-
Book Value(₹)
397.41
-
Debt-Equity Ratio
0.49
-
AGM Date
11-Jul-2025
-
EPS
59.59
-
P/E Ratio
24.92
Financials Ratios
-
Debt-Equity Ratio
0.03
-
Mar.Cap (₹Cr.)
119,944.61
-
RONW (%)
16.58
-
ROCE (%)
22.27
Score Board
-
Equity (₹ in Cr.)
161.54
-
BV (₹)
397.40
-
Sales( ₹ in Cr.)
19,044.85
-
NP (in Cr.)
4,813.38
-
NP Var(%)
19.0
-
Div%
800.0
-
CPS (₹)
66.70
-
EPS (₹)
59.60
-
Traded Value (₹ in Lakhs)
119,948.65
-
52 Week High
1,702.05
-
52 Week Low
1,335.00
-
Price BSE
1485.0
-
Price NSE
1,485.00
-
Market Capital( in Cr.)
119,948.65
-
P/C Ratio
22.30
-
P/E Ratio
24.90
-
Price Vs.BV
59.60
-
02-Jul-2025( 10:19)
Corporate News - Cipla... - Cipla will hold a meeting of t...
-
27-Jun-2025( 11:02)
Corporate News - Cipla... - Cipla has allotted 43,396 ful...
-
11-Jun-2025( 01:00)
Hot Pursuit - Cipla... - <p>Cipla Ltd is up for a fifth...
-
29-May-2025( 06:50)
Corporate News - Cipla... - <P>Cipla announced that C...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 19,044.85 | 16,574.34 | 14,345.34 | 15,380.82 | 11,302.71 | 12,659.15 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 19,044.85 | 16,574.34 | 14,345.34 | 15,380.82 | 11,302.71 | 12,659.15 |
Other Income | 1,279.38 | 1,433.72 | 826.20 | 742.05 | 653.91 | 892.85 |
Stock Adjustments | 229.87 | -104.57 | -194.32 | 541.93 | -6.41 | 43.08 |
Total Income | 20,554.10 | 17,903.49 | 14,977.22 | 16,664.80 | 11,950.21 | 13,595.08 |
EXPENDITURE : | ||||||
Raw Materials | 5,699.59 | 4,977.62 | 4,739.89 | 6,467.54 | 4,097.20 | 4,362.29 |
Power and Fuel Cost | 290.24 | 271.66 | 257.07 | 247.58 | 234.58 | 253.95 |
Employee Cost | 3,054.87 | 2,688.51 | 2,380.68 | 2,122.02 | 1,703.58 | 1,911.08 |
Other Manufacturing Expenses | 1,374.94 | 997.59 | 710.80 | 994.55 | 906.09 | 921.04 |
Selling and Administration Expenses | 2,604.73 | 2,510.53 | 2,334.97 | 2,107.17 | 1,578.59 | 2,093.92 |
Miscellaneous Expenses | 471.91 | 539.71 | 560.62 | 272.66 | -291.15 | 452.66 |
Employee Benefit Expenses | 3,054.87 | 2,688.51 | 2,380.68 | 2,122.02 | 1,703.58 | 1,911.08 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 13,496.28 | 11,985.62 | 10,984.03 | 12,211.52 | 8,228.89 | 9,994.94 |
Operating Profit | 7,057.82 | 5,917.87 | 3,993.19 | 4,453.28 | 3,721.32 | 3,600.14 |
Interest | 15.11 | 20.25 | 22.27 | 26.93 | 45.07 | 36.05 |
Gross Profit | 7,042.71 | 5,897.62 | 3,970.92 | 4,426.35 | 3,676.25 | 3,564.09 |
Depreciation | 573.89 | 587.59 | 595.91 | 546.62 | 468.62 | 599.78 |
Profit Before Tax | 6,468.82 | 5,310.03 | 3,375.01 | 3,879.73 | 3,207.63 | 2,964.31 |
Current Tax | 1,360.32 | 1,226.69 | 901.63 | 949.49 | 756.27 | 545.96 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -49.15 | 6.09 | -40.09 | -27.69 | -16.92 | 100.18 |
Reported Net Profit | 5,157.65 | 4,077.25 | 2,513.47 | 2,957.93 | 2,468.28 | 2,318.17 |
Extraordinary Items | 344.27 | 42.92 | -41.59 | 48.88 | 39.09 | 91.40 |
Adjusted Net Profit | 4,813.38 | 4,034.33 | 2,555.06 | 2,909.05 | 2,429.19 | 2,226.77 |
Adjustment below Net Profit | -12.96 | -74.47 | -10.52 | 18.48 | 13.71 | -49.53 |
P & L Balance brought forward | 22,950.83 | 19,634.22 | 17,534.77 | 14,961.71 | 12,479.72 | 10,828.56 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 1,049.83 | 686.17 | 403.50 | 403.35 | 0.00 | 617.48 |
P & L Balance carried down | 27,045.69 | 22,950.83 | 19,634.22 | 17,534.77 | 14,961.71 | 12,479.72 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 322.49 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 800.00 | 650.00 | 425.00 | 250.00 | 250.00 | 200.00 |
Dividend Per Share(Rs) | 16.00 | 13.00 | 8.50 | 5.00 | 5.00 | 4.00 |
Earnings Per Share-Unit Curr | 63.86 | 50.50 | 31.14 | 36.66 | 30.61 | 28.75 |
Earnings Per Share(Adj)-Unit Curr | 63.86 | 50.50 | 31.14 | 36.66 | 30.61 | 28.75 |
Book Value | 397.46 | 346.49 | 305.25 | 279.05 | 247.10 | 215.85 |
Book Value(Adj)-Unit Curr | 397.46 | 346.49 | 305.25 | 279.05 | 247.10 | 215.85 |